Evidence map›Paper›PMID 36743306›Full record

ArticleFrontiers in cellular and infection microbiology2023

Polymorphisms of the

Mengzhu He, Min Liu, Jiawei Geng, Li Liu, Peng Huang, Ming Yue, Xueshan Xia, A-Mei Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Foods (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mengzhu HeFaculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan, China.
Min LiuFaculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan, China.
Jiawei GengDepartment of Infectious Diseases, The First People's Hospital of Yunnan Province, Yunnan, China.
Li LiuFaculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan, China.
Peng HuangSchool of Public Health, Nanjing Medical University, Nanjing, China.
Ming YueSchool of Public Health, Nanjing Medical University, Nanjing, China.
Xueshan XiaFaculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan, China.
A-Mei ZhangFaculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, Yunnan, China.
Kunming University of Science and Technology · CNFirst People's Hospital of Yunnan Province · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hepatitis C virus (HCV) infection was the primary reason causing critical hepatic Q7 diseases. Although direct-acting antiviral agents (DAA) were widely used in clinics, anti-drug mutation, the outcome of patients with different viral subtypes, and recurrence suggested that HCV pathogenic mechanism should be studied further. HCV infection, replication, and outcome were influenced by the IFNL4 and itsdownstream genes (MxA and MxB). However, whether genetic polymorphisms of these genes played necessary roles required verification in the Yunnan population. Methods and Results: After analyzing the genotypes and allele frequencies of seven single nucleotide polymorphisms (SNP), we found the association between the genotype and allele frequencies of rs11322783 in the IFNL4 gene and HCV infection in Yunnan population. Furthermore, the genetic polymorphisms of the MxA and MxB genescould influence liver function of HCV patients. The indirect bilirubin (IBIL) and albumin (ALB) levels showed significant differences among HCV patients, who carried various genotypes. The IBIL levels were associated with genotypes of rs17000900 (P= 0.025) and rs2071430 (P= 0.037) in the MxA gene, and ALB levels were associated with genotypes of rs2838029 (P= 0.010) in the MxB gene. Similarly, the genotypes of SNPs also showed significant difference in patients infected with subtype 3a (P=0.035) and 2a (P=0.034). However, no association was identified between expression level and SNPs of the MxA and MxB genes. Furthermore, HCV subtype 3b was found to be the predominantly epidemic strain in Yunnan Province. Conclusion: In conclusion, the association between biochemical indices/HCV subtypes and SNPs in the MxA and MxB genes was identified in Yunnan HCV population.

Indexed as

Hepatitis CHepatitis C, ChronicMyxovirus Resistance ProteinsAntiviral AgentsChinaGenotypeHepacivirusHumansInterferon LambdaInterleukinsPolymorphism, Single NucleotideAntiviral AgentsIFNL4 protein, humanInterferon LambdaInterleukinsMX1 protein, humanMX2 protein, humanMyxovirus Resistance Proteinsbiochemical indicesHCV infectionMxAMxBsubtype

Identifiers

PMID36743306
PMCPMC9892934
OpenAlexW4317401530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.